Literature DB >> 9409221

Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.

V Anber1, J S Millar, M McConnell, J Shepherd, C J Packard.   

Abstract

The specific interaction of lipoproteins with arterial wall constituents, particularly proteoglycans (APG), is believed to play an important role in the development of atherosclerosis. The objective of this study was to examine the interaction of apolipoprotein B (apoB) containing lipoprotein subfractions (VLDL1, Sf 60 to 400; VLDL2, Sf 20 to 60; IDL1, Sf 16 to 20; IDL2, Sf 12 to 16; LDLA, Sf 8 to 12; and LDLB, Sf 0 to 8) prepared by cumulative density gradient centrifugation with chondroitin sulfate-rich APG. Eighteen subjects were studied, and a similar pattern of interaction between the lipoprotein species and APG was found in all. The order of reactivity (as measured by increased turbidity due to insoluble complex formation) was IDL Sf 12 to 16 > or = LDL Sf 8 to 12 > LDL Sf 0 to 8 > IDL Sf 16 to 20 >> VLDL Sf 20 to 60 > VLDL Sf 60 to 400. When the subjects were divided on the basis of their LDL subfraction profile, the extent of insoluble complex formation was highest in the group in which small, dense LDLIII was predominant; intermediate in the group whose LDL was mainly LDLII; and lowest in the group with a high proportion of LDLI (the mean reactivity, AU at 600 nm. of APG with IDL Sf 12 to 16 and LDL Sf 8 to 12 was 0.66; 0.62 and 0.46, 0.43 and 0.20, and 0.21 for the three groups, respectively). Fibrate lipid-lowering treatment decreased the percentage of LDLIII and increased the percentage of LDLI within total LDL and reduced the reactivity of all apoB-containing lipoprotein fractions toward APG. Sialic acid content varied in different lipoprotein subfractions, being the highest in VLDL and lowest in LDL. However, across lipoprotein species, it did not significantly correlate with APG-binding reactivity, suggesting that other factors are important in determining the interaction of lipoproteins with APG. Modification of LDL arginine and lysine residues abolished the ability of the lipoprotein to interact with APG, a finding that supports the hypothesis that the interaction is dependent on key positively charged amino acids on apoB. These findings demonstrate that (1) the overall reactivity of apoB-containing lipoproteins is greatest in individuals with small, dense LDL and (2) within an individual, IDL of Sf 12 to 16 is the most reactive species, and this may in part explain the positive correlation between IDL and risk of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409221     DOI: 10.1161/01.atv.17.11.2507

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

Review 1.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  The content of lipoperoxidation products in normal and atherosclerotic human aorta.

Authors:  V V Tertov; V V Kaplun; I A Mikhailova; I V Suprun; A N Orekhov
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

Review 3.  The role of fibric acid derivatives in the secondary prevention of coronary heart disease.

Authors:  J Krakoff; B S Vela; E A Brinton
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

Review 4.  Acidification of the intimal fluid: the perfect storm for atherogenesis.

Authors:  Katariina Öörni; Kristiina Rajamäki; Su Duy Nguyen; Katariina Lähdesmäki; Riia Plihtari; Miriam Lee-Rueckert; Petri T Kovanen
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

5.  Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

Authors:  Nuntakorn Thongtang; Margaret R Diffenderfer; Esther M M Ooi; P Hugh R Barrett; Scott M Turner; Ngoc-Anh Le; W Virgil Brown; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2017-04-09       Impact factor: 5.922

6.  Thermal transitions in human very-low-density lipoprotein: fusion, rupture, and dissociation of HDL-like particles.

Authors:  Madhumita Guha; Cheryl England; Haya Herscovitz; Olga Gursky
Journal:  Biochemistry       Date:  2007-05-01       Impact factor: 3.162

7.  Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Ian H de Boer; Brad C Astor; Holly Kramer; Walter Palmas; Kyle Rudser; Stephen L Seliger; Michael G Shlipak; David S Siscovick; Michael Y Tsai; Bryan Kestenbaum
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

8.  Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles.

Authors:  Vasilis Tsimihodimos; Irene Gazi; Christina Kostara; Alexandros D Tselepis; Moses Elisaf
Journal:  Lipids       Date:  2007-04-11       Impact factor: 1.880

9.  Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis.

Authors:  Ian H de Boer; Brad C Astor; Holly Kramer; Walter Palmas; Stephen L Seliger; Michael G Shlipak; David S Siscovick; Michael Y Tsai; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 8.237

Review 10.  Smooth Muscle Cell-Proteoglycan-Lipoprotein Interactions as Drivers of Atherosclerosis.

Authors:  Sima Allahverdian; Carleena Ortega; Gordon A Francis
Journal:  Handb Exp Pharmacol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.